Intellia Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LEONARD JOHN M | President and CEO | Award / Grant | 113,586 | — | — | 960,072 | Mar 1, 2024 |
| Hicks Derek | EVP, Chief Business Officer | Award / Grant | 29,393 | — | — | 66,380 | Mar 1, 2024 |
| Goddard Glenn | EVP, Chief Financial Officer | Award / Grant | 28,628 | — | — | 69,213 | Mar 1, 2024 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Sale | 1,608 | $28.66 | $46,085 | 44,594 | Jan 8, 2024 |
| LEONARD JOHN M | President and CEO | Sale | 19,223 | $29.46 | $566,310 | 846,486 | Jan 3, 2024 |
| Lebwohl David | EVP, Chief Medical Officer | Sale | 5,843 | $29.46 | $172,135 | 54,372 | Jan 3, 2024 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Sale | 5,532 | $29.46 | $162,973 | 46,202 | Jan 3, 2024 |
| Goddard Glenn | EVP, Chief Financial Officer | Sale | 5,365 | $29.46 | $158,053 | 40,585 | Jan 3, 2024 |
| Hicks Derek | EVP, Chief Business Officer | Sale | 3,877 | $29.46 | $114,216 | 36,987 | Jan 3, 2024 |
| BASTA JAMES | EVP, General Counsel | Sale | 3,805 | $29.46 | $112,095 | 51,474 | Jan 3, 2024 |
| Clark Eliana | EVP, Chief Technical Officer | Sale | 4,301 | $29.46 | $126,707 | 40,845 | Jan 3, 2024 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Option Exercise | 3,500 | — | — | 51,734 | Jan 1, 2024 |
| Lebwohl David | EVP, Chief Medical Officer | Option Exercise | 3,187 | — | — | 60,215 | Jan 1, 2024 |
| LEONARD JOHN M | President and CEO | Option Exercise | 7,848 | — | — | 865,709 | Jan 1, 2024 |
| Goddard Glenn | EVP, Chief Financial Officer | Option Exercise | 3,062 | — | — | 45,950 | Jan 1, 2024 |
| Bhanji Muna | — | Sale | 265 | $23.90 | $6,334 | 11,996 | Oct 31, 2023 |
| Bhanji Muna | — | Sale | 265 | $42.33 | $11,217 | 12,261 | Jul 31, 2023 |
| Bhanji Muna | — | Sale | 1,867 | $39.30 | $73,373 | 12,526 | Jul 6, 2023 |
| Clark Eliana | EVP, Chief Technical Officer | Sale | 360 | $40.51 | $14,584 | 45,146 | Jul 3, 2023 |
| Clark Eliana | EVP, Chief Technical Officer | Sale | 5,000 | $45.00 | $225,000 | 45,146 | Jun 20, 2023 |
| CHASE WILLIAM J | — | Award / Grant | 1,673 | — | — | 18,956 | Jun 14, 2023 |
| Verwiel Frank | — | Award / Grant | 4,425 | — | — | 11,716 | Jun 14, 2023 |
| Keresty Georgia | — | Award / Grant | 4,425 | — | — | 16,146 | Jun 14, 2023 |
| GOODMAN JESSE | — | Award / Grant | 4,425 | — | — | 11,716 | Jun 14, 2023 |
| Crowley John F | — | Award / Grant | 4,425 | — | — | 11,716 | Jun 14, 2023 |
| Cohen Fred E | — | Award / Grant | 4,425 | — | — | 41,716 | Jun 14, 2023 |
| Bhanji Muna | — | Award / Grant | 4,425 | — | — | 14,393 | Jun 14, 2023 |
| CHASE WILLIAM J | — | Award / Grant | 10,483 | — | — | 17,283 | Apr 14, 2023 |
| Hicks Derek | EVP, Chief Business Officer | Award / Grant | 23,558 | — | — | 40,864 | Mar 1, 2023 |
| Goddard Glenn | EVP, Chief Financial Officer | Award / Grant | 27,484 | — | — | 42,888 | Mar 1, 2023 |
| LEONARD JOHN M | President and CEO | Award / Grant | 91,036 | — | — | 857,861 | Mar 1, 2023 |
| Lebwohl David | EVP, Chief Medical Officer | Award / Grant | 30,674 | — | — | 56,361 | Mar 1, 2023 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Award / Grant | 29,938 | — | — | 47,567 | Mar 1, 2023 |
| Clark Eliana | EVP, Chief Technical Officer | Award / Grant | 24,539 | — | — | 39,012 | Mar 1, 2023 |
| BASTA JAMES | EVP, General Counsel | Award / Grant | 24,539 | — | — | 44,098 | Mar 1, 2023 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Sale | 689 | $39.10 | $26,940 | 17,629 | Jan 4, 2023 |
| LEONARD JOHN M | President and CEO | Sale | 6,673 | $37.21 | $248,302 | 766,825 | Jan 4, 2023 |
| Hicks Derek | EVP, Chief Business Officer | Sale | 1,812 | $37.21 | $67,425 | 17,306 | Jan 4, 2023 |
| Lebwohl David | EVP, Chief Medical Officer | Sale | 2,574 | $37.21 | $95,779 | 25,687 | Jan 4, 2023 |
| Goddard Glenn | EVP, Chief Financial Officer | Sale | 2,427 | $37.21 | $90,309 | 15,404 | Jan 4, 2023 |
| BASTA JAMES | EVP, General Counsel | Sale | 1,138 | $37.21 | $42,345 | 19,559 | Jan 4, 2023 |
| Clark Eliana | EVP, Chief Technical Officer | Sale | 105 | $51.74 | $5,433 | 16,165 | Jan 3, 2023 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Option Exercise | 3,500 | — | — | 22,467 | Jan 1, 2023 |
| LEONARD JOHN M | President and CEO | Option Exercise | 7,848 | — | — | 773,498 | Jan 1, 2023 |
| Lebwohl David | EVP, Chief Medical Officer | Option Exercise | 3,187 | — | — | 28,261 | Jan 1, 2023 |
| Goddard Glenn | EVP, Chief Financial Officer | Option Exercise | 3,062 | — | — | 17,831 | Jan 1, 2023 |
| Verwiel Frank | — | Award / Grant | 5,197 | — | — | 7,291 | Jun 14, 2022 |
| Keresty Georgia | — | Award / Grant | 5,197 | — | — | 11,721 | Jun 14, 2022 |
| GOODMAN JESSE | — | Award / Grant | 5,197 | — | — | 7,291 | Jun 14, 2022 |
| FORMELA JEAN FRANCOIS | — | Award / Grant | 5,197 | — | — | 7,291 | Jun 14, 2022 |